Latest News about CRL
Recent news which mentions CRL
Wall Street Pulls Back After Early Gains As Tariff Uncertainties Persist: What's Driving Markets Monday?
April 14, 2025
From Benzinga
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing
April 14, 2025
From Benzinga
Wall Street Rebounds, JPMorgan Jumps On Strong Q1 Earnings: What's Driving Markets Friday?
April 11, 2025
From Benzinga
From Benzinga
Demystifying Charles River: Insights From 10 Analyst Reviews
March 21, 2025
Tickers
CRL
From Benzinga
From Benzinga
From Benzinga
Earnings Scheduled For February 19, 2025
February 19, 2025
From Benzinga
This STMicroelectronics Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
January 22, 2025
From Benzinga
From Benzinga
Charles River Q3 Earnings: CEO Notes Improved Biotech Funding And Stabilizing Demand - Here's Why
November 06, 2024
From Benzinga
S&P 500, Dow Hit Record Highs After Trump Win; Fear Index Drops 20%
November 06, 2024
From Benzinga
P/E Ratio Insights for Charles River
October 25, 2024
From Benzinga
This Ferguson Enterprises Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
October 23, 2024
From Benzinga
From Benzinga
From Benzinga
Evaluating Charles River: Insights From 12 Financial Analysts
October 07, 2024
Tickers
CRL
From Benzinga
The Analyst Verdict: Charles River In The Eyes Of 10 Experts
September 20, 2024
Tickers
CRL
From Benzinga
Intel, Moderna And Dollar General Were Among Top 10 Large Cap Losers In August: Are The Others In Your Portfolio?
September 08, 2024
From Benzinga
Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers
August 31, 2024
From Benzinga
Warner Bros, Airbnb And Monster Beverage Are Among Top 10 Large Cap Losers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
August 11, 2024
From Benzinga
EXCLUSIVE: Oragenics' Concussion Drug Clears FDA-Required Cardiotoxicity Testing, Planning For Phase Trials Underway
August 08, 2024
From Benzinga
From Benzinga
Wall Street Ends Wednesday In The Red As Risk Sentiment Remains Fragile: S&P 500 Movers At The Close
August 07, 2024
From Benzinga
Charles River Laboratories Stock Sinks As It Warns Of Continued Biotech Demand Slump, Lowers Forecast
August 07, 2024
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.